This study is in progress, not accepting new patients
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Summary
- Eligibility
- for people ages 2-35 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
- ID
- NCT02823145
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 373 people participating
- Last Updated